Medical-grade platelet-rich plasma PRP Therapy and Exosome Therapy deliver concentrated growth factors and biologically active molecules directly to injured tissues, jumpstarting natural repair, reducing inflammation, and helping you regrow cartilage and restore function
This allows for deep tissue penetration, immune modulation, and whole-body collagen remodeling
This is meaningful early-phase data, but it falls far short of the Phase III trial evidence that would be required for FDA approval
Copper binding occurs through histidine imidazole nitrogen and N-terminal amino group, forming stable 1:1 complex
This ongoing research will also provide the scientific community and healthcare providers with the evidence needed to make informed decisions about incorporating BPC 157 into treatment protocols
In summary, epithalon has been found to: Increase the lifespan of animal test subjects (mice and fruit flies) Restore the circadian rhythm of melatonin and cortisol production in animal test subjects (rhesus monkeys) Prolong the integrity of the eye retina in animal test subjects (rats) Improve visual functions in elderly patients with age-related difficulties Despite these promising results, formal research into epithalon and anti-aging remains lacking, prompting researchers to actively explore the peptide